April 18, 2017 Share this...Facebook0emailLinkedin0TwitterWarren Rose, associate professor (CHS) in the Pharmacy Practice Division, will present results of a new antibiotic combination therapy for severe infections at the European Congress on Clinical Microbiology and Infectious Diseases (ECCMID). ECCMID is a premier international meeting dedicated to infectious diseases and therapy. The meeting is held annually and draws a select group of clinicians and scientists from around the world representing academia, clinical practice, and industry. The 2017 conference will be held April 22-25 in Vienna, Austria. Rose’s research interests include antimicrobial resistance and pharmacodynamics and antimicrobial effects on host-pathogen interactions. This study also involved Erin McCreary, PGY2 in infectious diseases and Lucas Schulz, PharmD ’08, coordinator in infectious diseases, Department of Pharmacy at UW Health.